Publications by authors named "Mathieu Seynaeve"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

7,361

Total Likes

876

Extended Reach

1,762,148

Social Features

234
5
5-Methoxy-N,N-dimethyltryptamine (5-MeO-DMT) for alcohol use disorder: An open-label, phase 2, proof-of-concept, clinical trial.
John Marsden, Michael Kelleher, Fiona Dunbar, Anna O Ermakova, Luke Mitcheson, Mathieu Seynaeve

Addiction· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mapping the phenomenology of intranasal 5-MeO-DMT in psychedelic-naïve healthy adults.
Anna O Ermakova, Fiona Dunbar, Mathieu Seynaeve, Raphaël Millière

Sci Rep· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low-dose psilocybin in short-lasting unilateral neuralgiform headache attacks: results from an open-label phase Ib ascending dose study.
James Rucker, Matt Butler, Sadie Hambleton, Catherine Bird, Mathieu Seynaeve

Headache· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1, placebo-controlled, single ascending dose trial to evaluate the safety, pharmacokinetics and effect on altered states of consciousness of intranasal BPL-003 (5-methoxy--dimethyltryptamine benzoate) in healthy participants.
James Jonathan Rucker, Claire Roberts, Mathieu Seynaeve, Allan H Young, Ben Suttle

J Psychopharmacol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Views on Using Psychoactive Substances to Self-Manage Functional Neurological Disorder: Online Patient Survey Results.
Matthew Butler, Mathieu Seynaeve, Abigail Bradley-Westguard, Jianan Bao, Ania Crawshaw

J Neuropsychiatry Clin Neurosci· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
International online survey of 1048 individuals with functional neurological disorder.
Matthew Butler, Oliver Shipston-Sharman, Mathieu Seynaeve, Jianan Bao, Susannah Pick

Eur J Neurol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perspectives on psychedelic treatment and research in eating disorders: a web-based questionnaire study of people with eating disorders.
Fiona Harding, Mathieu Seynaeve, Johanna Keeler, Hubertus Himmerich, Janet Treasure

J Integr Neurosci· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Psychedelic treatment of functional neurological disorder: a systematic review.
Matthew Butler, Mathieu Seynaeve, Timothy R Nicholson, Susannah Pick, Richard A Kanaan

Ther Adv Psychopharmacol· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical factors associated with progression to dementia in people with late-life depression: a cohort study of patients in secondary care.
Georgia Peakman, Nishshanka Karunatilake, Mathieu Seynaeve, Gayan Perera, Dag Aarsland

BMJ Open· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis